These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11106303)

  • 21. The value of primate models for studying human immunodeficiency virus pathogenesis.
    Levy JA
    J Med Primatol; 1996 Jun; 25(3):163-74. PubMed ID: 8892037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feline immunodeficiency virus infection: a valuable model to study HIV-1 associated encephalitis.
    Fletcher NF; Brayden DJ; Brankin B; Callanan JJ
    Vet Immunol Immunopathol; 2008 May; 123(1-2):134-7. PubMed ID: 18289700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population dynamics of feline immunodeficiency virus within cat populations.
    Courchamp F; Pontier D; Langlais M; Artois M
    J Theor Biol; 1995 Aug; 175(4):553-60. PubMed ID: 7475091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feline immunodeficiency virus infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine-5'-triphosphate-loaded erythrocytes.
    Magnani M; Rossi L; Fraternale A; Silvotti L; Quintavalla F; Piedimonte G; Matteucci D; Baldinotti F; Bendinelli M
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1179-86. PubMed ID: 7826702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The development of a vaccine against feline immunodeficiency virus.
    Hosie MJ
    Br Vet J; 1994; 150(1):25-39. PubMed ID: 8025833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methamphetamine and AIDS: 1HMRS studies in a feline model of human disease.
    Cloak CC; Chang L; Ernst T; Barr MC; Huitron-Resendiz S; Sanchez-Alavez M; Phillips TR; Henriksen S
    J Neuroimmunol; 2004 Feb; 147(1-2):16-20. PubMed ID: 14741420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contribution of animal models in the understanding of AIDS encephalopathy].
    Boche D; Gray F; Khatissian E; Hurtrel M; Montagnier L; Hurtrel B
    Arch Anat Cytol Pathol; 1997; 45(2-3):75-85. PubMed ID: 9382613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NIH faces action over HIV cat study.
    Check E
    Nature; 2002 Jan; 415(6868):106. PubMed ID: 11805798
    [No Abstract]   [Full Text] [Related]  

  • 29. Addictive drug increases HIV replication and mutation.
    Ahmad K
    Lancet Infect Dis; 2002 Aug; 2(8):456. PubMed ID: 12150837
    [No Abstract]   [Full Text] [Related]  

  • 30. Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence.
    Maingat FG; Polyak MJ; Paul AM; Vivithanaporn P; Noorbakhsh F; Ahboucha S; Baker GB; Pearson K; Power C
    FASEB J; 2013 Feb; 27(2):725-37. PubMed ID: 23150523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of immunodeficiency virus in oocytes via intracytoplasmic injection: possible but extremely unlikely.
    Steenvoorden MM; Cornelissen M; van Leeuwen E; Schuurman NM; Egberink HF; Berkhout B; van der Veen F; Repping S
    Fertil Steril; 2012 Jul; 98(1):173-7. PubMed ID: 22584022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal disease in cats infected with feline immunodeficiency virus.
    Baxter KJ; Levy JK; Edinboro CH; Vaden SL; Tompkins MB
    J Vet Intern Med; 2012; 26(2):238-43. PubMed ID: 22269003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of CXCR4 in the brain of feline immunodeficiency virus infected cat.
    Koirala TR; Sharma S; Morikawa S; Ishida T
    Indian J Pathol Microbiol; 2000 Jul; 43(3):285-90. PubMed ID: 11218674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing anti-HIV drugs in the FIV model.
    North TW; LaCasse RA
    Nat Med; 1995 May; 1(5):410-1. PubMed ID: 7585083
    [No Abstract]   [Full Text] [Related]  

  • 35. Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infected cats: a model for HIV infection in chronic opiate abusers.
    Barr MC; Huitron-Resendiz S; Sanchez-Alavez M; Henriksen SJ; Phillips TR
    Drug Alcohol Depend; 2003 Nov; 72(2):141-9. PubMed ID: 14636969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Animal models used for the evaluation of antiretroviral therapies.
    Dias AS; Bester MJ; Britz RF; Apostolides Z
    Curr HIV Res; 2006 Oct; 4(4):431-46. PubMed ID: 17073618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.
    Theodore S; Cass WA; Nath A; Maragos WF
    Curr HIV Res; 2007 May; 5(3):301-13. PubMed ID: 17504172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs of abuse and HIV infection/replication: implications for mother-fetus transmission.
    Wang X; Ho WZ
    Life Sci; 2011 May; 88(21-22):972-9. PubMed ID: 21056582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Partial characterization and tissue distribution of the feline mu opiate receptor.
    Billet O; Billaud JN; Phillips TR
    Drug Alcohol Depend; 2001 Apr; 62(2):125-9. PubMed ID: 11245968
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic Impairment of the Neurovascular Unit by HIV-1 Infection and Methamphetamine Use: Implications for HIV-1-Associated Neurocognitive Disorders.
    Fattakhov N; Torices S; Stangis M; Park M; Toborek M
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.